淋巴细胞抗原96(LY96)重组蛋白

Recombinant Lymphocyte Antigen 96 (LY96)

MD-2; ESOP1

  • 淋巴细胞抗原96(LY96)重组蛋白产品包装(模拟)
  • 淋巴细胞抗原96(LY96)重组蛋白产品包装(模拟)
  • 淋巴细胞抗原96(LY96)重组蛋白Figure . Gene Sequencing (extract)
  • RPH705Mu01.jpgSDS-PAGE图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号适用物种:Mus musculus (Mouse,小鼠)应用(仅供研究使用,不用于临床诊断!)
RPH705Mu01淋巴细胞抗原96(LY96)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAH705Mu01淋巴细胞抗原96(LY96)多克隆抗体WB; IHC
LAH705Mu71淋巴细胞抗原96(LY96)多克隆抗体(生物素标记)WB

参考文献

杂志参考文献
34Study of the functional consequences of BAG3 molecular variants associated with human dilated cardiomyopathy[Oxfordjournals: Source]
34The association of cardiovascular reactivity to mental stress with mortality in patients with chronic heart failure[Oxfordjournals: Source]
Heart failure: basic mechanismsThe immune protein MD-2 is a novel independent predictor for long term mortality in dilated cardiomyopathy and non-inferior to nt-pro BNP[Oxfordjournals:Source]